Created in 2000 (Belgium), Zyrtec Cetirizine hydrochloride 10/ film-coated tablets 10mg own 359 sister brands and 2214 competing brands. The Zyrtec Cetirizine hydrochloride 10/ film-coated tablets 10mg brand is owned by UCB, a company listed in Bruxelles. Its International Securities Identification Number (ISIN) is BE0003739530. Zyrtec Cetirizine hydrochloride 10/ film-coated tablets 10mg belongs to the Biotechnology business sector.

Zyrtec Cetirizine hydrochloride 10/ film-coated tablets 10mg is a brand of UCB (UCB) Share price

Share price and profitability of the share UCB (Zyrtec Cetirizine hydrochloride 10/ film-coated tablets 10mg)

Buy UCB share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested EUR 122.00

Portfolio valuation
UCB (Zyrtec Cetirizine hydrochloride 10/ film-coated tablets 10mg) over 5 years* EUR 211.77

Stock market history UCB (Zyrtec Cetirizine hydrochloride 10/ film-coated tablets 10mg)

Desirable brands that generate Pricing Power and therefore stock market performance

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more